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BACKGROUND: Recent data suggest a link between blood leukocyte DNA methylation, and cancer risk. However, reports on DNA
methylation from a prospective study are unavailable for gastric cancer.
METHODS: We explored the association between methylation in pre-diagnostic blood leukocyte DNA and gastric cancer risk in a
case–control study nested in the prospective Shanghai Women’s Health Study cohort. Incident gastric cancer cases (n¼192) and
matched controls (n¼384) were included in the study. Methylation of Alu and long interspersed nucleotide elements (LINE)-1 were
evaluated using bisulphite pyrosequencing. Odds ratios (ORs) and 95% confidence intervals (CI) were calculated from logistic
regression adjusting for potential confounders.
RESULTS: Alu methylation was inversely associated with gastric cancer risk, mainly among cases diagnosed one or more years after
blood collection. After excluding cases diagnosed during the first year of follow-up, the ORs for the third, second, and first quartiles of
Alu methylation compared with the highest quartile were 2.43 (1.43–4.13), 1.47(0.85–2.57), and 2.22 (1.28–3.84), respectively. This
association appeared to be modified by dietary intake, particularly isoflavone. In contrast, LINE-1 methylation levels were not
associated with gastric cancer risk.
CONCLUSION: Evidence from this prospective study is consistent with the hypothesis that DNA hypomethylation in blood leukocytes
may be related to cancer risk, including risk of gastric cancer.
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Although its incidence has declined in the past decades, gastric cancer
is still the fourth most commonly diagnosed cancer and the second
most common cause of cancer death in the world (Jemal et al, 2011).
Helicobacter pylori (H. pylori) infection, dietary factors (e.g., low
vegetable and fruit intake, and high salt intake), and smoking have
been associated with an elevated risk of this disease (Schottenfeld and
Fraumeni, 2006). Genetic variations also have been suggested to have
a role in gastric cancer development (Gao et al, 2009; Peleteiro et al,
2010). However, the molecular aetiology of gastric cancer remains
unclear and we lack biomarkers for risk prediction for this disease.
Epigenetic changes, which may represent an archive of past
carcinogenic exposure (Jirtle and Skinner, 2007; Skinner, 2011),
could be considered such candidates.
DNA methylation, the covalent addition of a methyl group, is an
epigenetic event that affects cell function by altering gene expression.
The cytosine nucleotide is the major target of methylation reaction
and the product is usually 5-methyl-deoxycytidine (5-mdC). Changes
in DNA methylation patterns are hypothesised to be involved in
carcinogenesis (Ehrlich, 2002). Global DNA methylation, that is, the
degree of methyl attachment to cytosine residues of DNA sequences
across the genome, is typically reduced in a wide range of tumours (a
phenomenon termed as ‘global hypomethylation’), including gastric
cancer (Cravo et al, 1996; Hsiung et al, 2007; Moore et al,2 0 0 8 ;
Guerrero-Preston et al, 2009). Global DNA methylation was
decreased among human gastric cancer cell lines (Kaneda et al,
2004; Jiang et al, 2008), which was usually associated
with chromosome instability (Watanabe and Maekawa, 2010).
Significantly decreased global methylation has also been shown in
gastric cancer tissue (Chalitchagorn et al, 2004; Suzuki et al, 2006)
and pre-cancer lesions (Cravo et al, 1996; Yamamoto et al, 2008).
Crave et al (1996) observed a graduated decrease in global DNA
methylation in gastric specimens from normal, superficial gastritis,
chronic atrophic gastritis with intestinal metaplasia, to intestinal type
of gastric carcinoma.
Repetitive elements represent a large portion of the human
genome and contain much of the CpG methylation found in
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ynormal human postnatal somatic tissues (Yang et al, 2004). Long
interspersed nucleotide elements (LINE) make up about 15% of
human genome with B0.5 million copies, and Alu-repetitive
elements make up about 10% of human genome with 1.4 million
copies. It is estimated that more than a third of DNA methylation
occurs in the repetitive sequences (Weisenberger et al, 2005), and
methylation levels of LINE-1 and Alu have been used as proxies for
global DNA methylation status (Bollati et al, 2007, 2009; Tarantini
et al, 2009).
Many studies on DNA methylation and gastric cancer to date
have been conducted by comparing tumour tissue DNA with
adjacent normal tissue DNA from cancer patients, and found
decreased global or repetitive elements DNA methylation
in tumour tissue compared with adjacent normal tissue (Chalitch-
agorn et al, 2004; Suzuki et al, 2006). Relatively fewer studies have
been conducted on DNA methylation change in other non-target
tissues (Chalitchagorn et al, 2004; Board et al, 2008). Methylation
status of some CpG sites could be passed from previous generations
as an inherited marker (Kile et al, 2010), or affected by aging or
environmental exposures as a whole organism throughout life
(Christensen et al, 2009). Changes of methylation in leukocyte DNA
have been shown to parallel other somatic tissues (McKay et al,
2011), and have been linked to susceptibility of certain cancers
(Marsit et al, 2011). Certainly, we could not rule out the possibility
that different tissues have different response to environmental
exposure and that methylation status in leukocytes may not fully
reflect the changes in the target tissue (McKay et al, 2011). We
previously observed suggestive associations between hypomethyla-
tion in Alu and LINE-1 in blood leukocyte DNA and gastric cancer
risk in a case–control study (Hou et al, 2010). To follow-up this
lead, we conducted a nested case–control study within the
Shanghai Women’s Health Study (SWHS) to prospectively examine
the relationship between gastric cancer risk and DNA methylation
in LINE-1 and Alu regions from pre-diagnostic blood leukocytes.
Methylation reactions depend on the availability of methyl
groups from S-adenosylmethionine, which are mainly derived
from foods that contain methionine, folic acid, and choline
(Lamprecht and Lipkin, 2003); intake deficiency of these foods has
been associated with decreased methylation level in colon and
gastric tissues (Kim et al, 2003; Galvan-Portillo et al, 2009). Other
lifestyle factors, such as alcohol drinking, cigarette smoking, and
vitamins use, have also been linked to DNA methylation change
and related with cancer status (Nan et al, 2005; Hillemacher et al,
2008). Furthermore, carriage of H. pylori has been suggested to
interact with DNA methylation and lead to gastric carcinogenesis
(Chan et al, 2003, 2007; Ushiku et al, 2007; Yamamoto et al, 2008;
Hino et al, 2009). We also explored effect modification by these a
priori factors on the methylation–cancer association.
MATERIALS AND METHODS
Study population
The SWHS; Zheng et al, 2005) is a prospective cohort comprised of
74942 women, aged 40–70 years at study entry (1997–2000), from
urban Shanghai, China. Participants were interviewed (response
rate 93%) to elicit information on demographic characteristics,
height and weight history, medical history, family cancer history,
menstrual and reproductive history, dietary habits, and other
lifestyle factors. Dietary intake was ascertained by a validated
food-frequency questionnaire that included frequency of
consumption (daily, weekly, monthly, yearly, or not at all) and
portion size of each serving (Epplein et al, 2010). Daily
consumption of isoflavone and folic acid from food was calculated
according to the nutrient content per gram of the food obtained
from the Chinese Food Composition Tables (Lee et al, 2009;
Epplein et al, 2010). In addition, 56831 participants provided a
10-ml blood sample collected into an EDTA vacutainer tube. Blood
samples were kept at 0–41C, transported on ice, and saved at
 701C within 6h after collection. DNA was extracted from blood
leukocytes with the standard phenol–chloroform method. Incident
cancer patients were identified by biennial in-person follow-up
interview and by annual linkage to the population-based Shanghai
Cancer Registry.
All incident gastric cancer cases (n¼192) diagnosed through
December 2009, who provided a blood sample, were included in
the current project. For each case, two cancer-free controls were
randomly selected from cohort members and matched to the cases
by age (±2 years), menopausal status at sample collection, date
(±30 days) and time (morning or afternoon) of blood draw, and
time since last meal (±2h).
This study was approved by the institutional review boards of all
participating study centers in China and the United States. All
participants provided written informed consent.
DNA methylation measurement
For the current study, 500ng DNA extracted from baseline buffy
coat sample for each case and control was treated with bisulphite
to convert unmethylated cytosine to uracil. Each assay was
compared with an internal control sample to monitor the
completion of bisulphite conversion. The bisulphite-treated DNA
was then used for PCR amplification of Alu and LINE-1 elements,
followed by pyrosequencing, a highly quantitative method as
previously described (Tarantini et al, 2009; Baccarelli et al, 2010),
to measure the degree of methylation for LINE-1 and Alu.
Methylation status was expressed as the percentage of methylated
cytosines over the total of methylated and unmethylated cytosines.
All of the 576 samples were tested in eight batches/plates.
Matched case and control trio samples were placed within the same
batch in random order. One negative control was included in each
batch. To assess variability of the assay, duplicates from each of
two QC subjects were randomly and blindly dispersed among
study samples in each of eight batches (total 32 QC samples).
Duplicate assays from bisulphate-converted DNA samples were
analysed for each subject and the average was used for statistical
analysis. The analytical variability (coefficient of variation
calculated from replicates of the QC samples) was 2.2% and
1.0% for Alu methylation and LINE-1 methylation, respectively.
Statistical analysis
DNA methylation levels were classified as quartiles for statistical
analysis according to their distributions in controls, and the
highest quartile was used as the reference group for risk
estimation. Logistic regression was used to estimate odds ratios
(ORs) and 95% confidence intervals (95% CI) for the association
between DNA methylation and gastric cancer risk. As there was
essentially no difference in the risk estimates between conditional
and unconditional logistic regressions, we reported results from
unconditional logistic regression. Adjustment for age, body mass
index (BMI), education, family history of gastric cancer, meno-
pause status, cigarette smoking, alcohol drinking, and use of
antibiotics and cold medicine 1 week before blood draw did not
modify the risk estimates appreciably (o5%). Among a subset of
subjects (67% of total subjects) with H. pylori infection status,
further adjustment for this variable did not alter risk estimates
either. Therefore, the results were reported from logistic regression
adjusted for age only.
Taking advantage of the prospective design of the SWHS, we
explored the effect of latency on the association between DNA
methylation and gastric cancer risk. For cases, latency was defined
as the time difference between blood draw and gastric cancer
diagnosis; for controls, latency was defined as the time difference
DNA methylation and gastric cancer
Y Gao et al
586












yfrom blood draw to the time their corresponding cases was
diagnosed with gastric cancer.
To explore whether the methylation-cancer association was
modified by selected exposure factors, we conducted analyses
stratified by family history of gastric cancer, menopause status, tea
drinking, dietary intake of isoflavone and folic acid, and intake of
vegetable and fruit. Dietary intake was dichotomously classified
into high vs low intake based on the median in controls.
Interactions were evaluated with log-likelihood ratio test compar-
ing models with and without the interaction term. All statistical
analyses were conducted with SAS 9.1 statistical software
(Rockville, MD, USA) and all tests were two-sided. An analysis
with P-value o0.05 was considered statistically significant.
RESULTS
A total of 192 gastric cancer cases and 384 individually matched
controls were included in the current analyses. Cases and controls
were similar with regard to age, BMI, education, family history of
gastric cancer, menopause status, recent non-steroidal anti-inflam-
matory drug and antibiotics use, vitamin B use, tea drinking, and
dietary intake (isoflavones, folic acid, vegetables, and fruits; Table 1).
Among subjects with information on H. pylori infection status, over
90% of cases and controls were positive. Smoking and alcohol
drinking were not prevalent in Chinese women. The median levels
of Alu and LINE-1 were nearly identical in cases and controls.
Compared with the highest quartile, decreased Alu methylation
was associated with increased gastric cancer risk overall, with risk
estimates of 2.17 (95% CI¼1.32–3.56), 1.37 (95% CI¼0.82–2.31),
and 1.85 (95% CI¼1.10–3.11) for the third, second, and the lowest
quartiles, respectively. When we stratified the analysis by latency,
however, we found that the associations for cases diagnosed within
the first year following blood draw were different from those for
cases diagnosed at a later time (Table 2). Within the first year of
blood draw, hypomethylation of Alu appeared inversely associated
with gastric cancer risk, although this observation was based on
small numbers of subjects and none of the risk estimates were
statistically significant (Table 2). For individuals whose gastric
cancer was diagnosed at X1 years after blood collection, risk was
elevated with hypomethylation of Alu, although not in a consistent
manner with either progression in hypomethylation or increasing
years since blood draw. For LINE-1 hypomethylation, there were
no consistent associations with gastric cancer risk, regardless of
the years since blood collection.
We explored whether selected exposures might modify the
association between hypomethylation in Alu and gastric cancer
risk. For this analysis, we excluded cases diagnosed within 1 year
of blood collection and their controls to minimise the potential
impact of preclinical cancer. The inverse associations between the
gastric cancer risk and Alu methylation tended to be stronger
among women who consumed tea regularly and had high levels of
intake of isoflavone, folic acid, or vegetable (Table 3). However,
only the interaction with dietary isoflavone intake reached
statistical significance (Pinteraction¼0.04). In contrast, there were
no consistent patterns of effect modification of the association
between LINE-1 methylation and gastric cancer risk by selected
exposures (Table 4).
DISCUSSION
In this exploratory study, we observed inverse associations
between gastric cancer risk and methylation of Alu, but not
LINE-1, in pre diagnostic blood leukocytes. The association with
Alu methylation appeared to be modified by years since blood
collection, with an inverse association observed only for cases
diagnosed X1 year after blood collection. Furthermore, this
association appeared to be modified by dietary intake, particularly
intake of isoflavone.
Our study has several advantages and limitations. First, the
study is nested within the population-based SWHS cohort, which
Table 1 Characteristics at baseline for gastric cancer cases and controls nested in the Shanghai Women’s Health Study
Characteristics
a Controls (n¼384) Cases (n¼192) P
b
Age (year) 61 (51–65) 61 (50–65) 0.97
Education
College/higher 39 (10.2) 12 (6.2) 0.27
High school 82 (21.4) 35 (18.2)
Middle school 109 (28.4) 57 (32.7)
Elementary/less 154 (40.1) 88 (45.8)
Family history of gastric cancer 28 (7.3) 16 (8.3) 0.66
Menopause 311 (81.0) 159 (83.2) 0.51
H. pylori positivity
c 260 (92.2) 136 (96.4) 0.09
Ever smoking 19 (5.0) 12 (6.2) 0.52
Ever alcohol use 8 (2.1) 3 (1.6) 0.67
NSAID/cold medication use within past week 36 (9.4) 12 (6.2) 0.20
Antibiotics use within past week 31 (8.1) 9 (4.7) 0.13
Vitamin B supplement use within past year 21 (5.5) 10 (5.2) 0.89
Tea drink regularly 111 (28.9) 43 (22.4) 0.10
Body mass index (kgm
 2) 24.3 ((22.4–26.5) 24.6 (22.3–27.3) 0.53
Dietary isoflavones intake (ug per day) 37.6 (21.7–57.7) 39.0 (20.9–53.3) 0.90
Dietary folic acid intake (ug per day) 280.7 (218.9–346.0) 286.3 (211.4–348.2) 0.73
Vegetables intake (g per day) 262.0 (178.7–366.3) 242.1 (155.5–371.0) 0.18
Fruit intake (g per day) 221.3 (121.8–352.3) 207.5 (95.9–323.9) 0.16
Alu methylation (%) 25.3 (25.0–25.6) 25.3 (24.95–25.5)
LINE-1 methylation (%) 85.2 (84.6–85.7) 85.1 (84.6–85.8)
Abbreviations: H. pylori¼Helicobacter pylori; LINE¼long interspersed nucleotide elements; NSAID=non-steroidal anti-inflammatory drug.
aContinuous variables are displayed as
median (interquartile) and categorical variables are displayed as frequency (percentage among cases or controls).
bP-values are calculated from paired t-test for continuous
variable and w
2-test for categorical variables.
cH. pylori status was only available for 423 subjects (141 cases and 282 controls).
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yis a well-characterised population of women at high risk for gastric
cancer. Second, DNA obtained from blood samples at baseline
allowed us to assess methylation status before cancer diagnosis, and
explore the latency effect on the associations. To our knowledge, this
is among the first prospective population-based study to date to
examine the association between DNA methylation and cancer risk.
In addition, detailed exposure information (i.e., dietary and other life
style factors) allowed us to explore potential effect modifications.
However, the sample size is relatively small, and we had limited
power to detect interactions with potential effect modifiers. Besides,
if donated blood samples of the participants of SWHS (75.8% of all
participants) were different from those who did not donate blood, it
could limit the generalisability of our results to those who did not
provide a blood sample.
To date, a few case–control studies have examined the
association between global DNA methylation in leukocytes and
risk of various cancers, including cancers of the head and neck,
stomach, breast, colon and rectum, and bladder (Pufulete et al,
2003; Hsiung et al, 2007; Moore et al, 2008; Choi et al, 2009; Hou
et al, 2010; Wilhelm et al, 2010; Cash et al, 2011). Though all of the
studies suggested an inverse association between global DNA
methylation and cancer risk, not all results were statistically
significant (Pufulete et al, 2003; Choi et al, 2009; Cash et al, 2011).
Only one study examined gastric cancer risk in relation to both Alu
and LINE-1 methylation in a Polish case–control study and found
insignificant inverse associations with both (Hou et al, 2010). We
did not observe a consistent dose-response effect with Alu
methylation, raising the possibility of chance variations. However,
the lack of linear association with methylation status has been
reported previously, such as the association between bladder
cancer and global DNA methylation evaluated directly with
50-methylcytosine (Moore et al, 2008), which might reflect a threshold
effect. Further evidence is needed to clarify the association between
peripheral leukocyte DNA methylation and gastric cancer risk.
Table 2 Association of Alu and LINE-1 methylation levels in blood leukocytes and risk of gastric cancer by latency
a
Q4 Q3 Q2 Q1
Ncase/control 95% CI Ncase/control 95% CI Ncase/control 95% CI Ncase/control 95% CI
Alu (%) X25.6 25.3–25.6 25.0–25.2 o25.0
Overall 36/111 1 64/91 2.17 (1.32–3.56) 44/99 1.37 (0.82–2.31) 48/80 1.85 (1.10–3.11)
o1 years 6/9 1 6/10 0.83 (0.17–4.15) 5/9 0.78 (0.16–3.91) 1/8 0.18 (0.02–1.91)
1–4.99 years 15/48 1 23/36 2.04 (0.94–4.46) 17/35 1.56 (0.69–3.54) 19/30 2.04 (0.90–4.62)
X5years 15/54 1 35/45 2.80 (1.36–5.78) 22/55 1.44 (0.68–3.07) 28/42 2.40 (1.14–5.07)
Pinteraction
b 0.30
LINE-1 (%) X85.7 85.1–85.6 84.5–85.0 o84.5
Overall 57/104 1 36/90 0.73 (0.44–1.21) 58/104 1.02 (0.64–1.60) 41/84 0.89 (0.54–1.46)
o1 years 3/7 1 7/12 1.36 (0.26–7.05) 6/10 1.40 (0.26–7.59) 2/6 0.78 (0.10–6.32)
1–4.99 years 14/13 1 13/35 0.60 (0.26–1.37) 18/40 0.71 (0.33–1.52) 19/38 079 (0.36–1.70)
X5years 30/59 1 16/44 0.71 (0.35–1.47) 34/54 1.23 (0.67–2.29) 20/40 0.98 (0.49–1.97)
Pinteraction
b 0.80
Abbreviations: CI=confidence interval; LINE¼long interspersed nucleotide elements.
aAdjusted for age; latency was defined as the time from blood draw
to cancer diagnosis for cases, and the same value was assigned to the matched controls.
bP-value for interaction tested by coding the Alu and LINE-1 quartiles as ordinal
variable (1,2,3,4). Bold entries indicate Po0.05.
Table 3 Association of Alu methylation levels in blood leukocytes and risk of gastric cancer by potential effect modifiers
a
Q4 Q3 Q2 Q1
Ncase/control OR (95%) Ncase/control OR (95%) Ncase/control OR (95%) Ncase/control OR (95%) P
b
Alu 30/102 1 58/81 2.43 (1.43–4.13) 39/90 1.47 (0.85–2.57) 47/72 2.22 (1.28–3.84)
Family history (yes) 3/9 1 4/5 2.71 (0.41–18.2) 3/5 1.99 (0.28–14.3) 5/7 2.42 (0.40–14.4) 0.92
Family history (no) 27/93 1 54/76 2.45 (1.41–4.25) 36/85 1.46 (0.82–2.61) 42/65 2.23 (1.25–3.97)
Menopause (yes) 22/82 1 49/62 2.93 (1.60–5.34) 37/77 1.78 (0.96–3.29) 38/62 2.27 (1.22–4.23) 0.99
Menopause (no) 8/20 1 9/19 1.31 (0.41–4.20) 2/13 0.35 (0.06–1.95) 9/10 2.18 (0.64–7.42)
Tea (yes) 2/28 1 17/28 8.54 (1.80–40.5) 13/24 7.59 (1.56–37.1) 10/21 6.73 (1.33–34.1) 0.31
Tea (no) 28/74 1 41/53 2.04 (1.13–3.71) 26/66 1.04 (0.56–1.95) 37/51 1.92 (1.04–3.52)
Isoflavone (high) 20/45 1 27/38 4.11 (1.82–9.29) 18/46 2.72 (1.16–6.35) 20/37 4.37 (1.89–10.1) 0.04
Isflavone (low) 10/57 1 31/43 1.59 (0.77–3.27) 21/44 0.88 (0.42–1.89) 27/35 1.21 (0.57–2.58)
Folic acid (high) 18/47 1 25/43 3.98 (1.82–8.68) 18/42 1.98 (0.88–4.45) 21/38 3.47 (1.54–7.78) 0.26
Folic acid (low) 12/55 1 33/38 1.50 (0.72–3.13) 21/48 1.11 (0.51–2.41) 26/34 1.42 (0.66–3.05)
Vegetable (high) 17/50 1 36/46 2.54 (1.13–5.70) 19/42 1.66 (0.74–3.70) 26/39 2.53 (1.12–5.74) 0.56
Vegetable (low) 13/52 1 22/35 2.30 (1.14–4.64) 20/48 1.34 (0.62–2.90) 21/33 1.95 (0.93–4.10)
Fruit (high) 12/44 1 31/41 2.17 (1.06–4.46) 18/47 1.58 (0.75–3.33) 24/43 2.58 (1.20–5.53) 0.41
Fruit (low) 18/58 1 27/40 2.80 (1.26–6.17) 21/43 1.41 (0.61–3.25) 23/29 2.07 (0.92–4.68)
Abbreviation: OR¼odds ratio.
aAdjusted for age ; subjects with latency less than 1 year were excluded.
bP-value for interaction tested by coding the Alu as ordinal variable (1,2,3,4).
Bold entries indicate Po0.05.
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yThough not statistically significant, we found that the associa-
tion between Alu methylation and gastric cancer risk was stronger
among individuals with longer latency. Certainly, this exploratory
finding warrants further research. Ideally, it would be most
informative if blood samples were available to monitor changes in
DNA methylation for the same persons at multiple time points
before cancer diagnosis.
We explored effect modification by several a priori factors and
found a significant interaction only with dietary isoflavone intake,
with a stronger association between gastric cancer risk and Alu
hypomethylation among individuals with high isoflavone intake.
This observation appears inconsistent with the known inhibitory
effect of isoflavones on cancer development (Gilbert and Liu,
2010). It is also possible that this apparent effect modification is a
chance occurrence.
Retro transposition (mobile genetic elements inserting into a
new location) of LINE-1 and Alu has been reported to increase
genomic instability, activate endogenous parasitic sequence, and
contribute to the transcriptional silencing of tumour-suppressor
genes in tissues, thus, leading to tumour development (Esteller and
Herman, 2002; Gilbert et al, 2002; Symer et al, 2002). In addition,
Alu and LINE-1 may also participate in regulating immune and
inflammatory responses (Li and Schmid, 2001; Hagan and Rudin,
2002). Emerging data from epidemiological studies suggest
different functional roles of Alu and LINE-1 in cancer initiation
and progression (Bollati et al, 2007; Rusiecki et al, 2008; Jintaridth
and Mutirangura, 2010). Though Alu and LINE-1 were correlated
to each other in tumour tissue (Choi et al, 2007), a correlation has
not always been observed in blood (Bollati et al, 2007; Rusiecki
et al, 2008). A study on breast cancer found increased cancer risk
associated with lower 5-mdC level in leukocyte DNA but not LINE-
1 methylation level; further, LINE-1 methylation was not correlated
with 5-mdC (Choi et al, 2009). Direct measurement of global
5-mdC is still needed to examine the role of global DNA
methylation in gastric cancer aetiology. In the present study, we
observed significantly increased risk of gastric cancer associated
with hypomethylation of Alu but not LINE-1, and the correlation
between LINE-1 methylation and Alu methylation among controls
was modest (correlation coefficient of determination R
2¼0.12).
Our findings seem to support the notion that Alu and LINE-1have
different roles in gastric carcinogenesis, but given the small
numbers in this study, we cannot rule out chance as an
explanation.
In summary, the results from this prospective study suggest that
DNA methylation of Alu, but not LINE-1, in blood leukocytes
might be inversely associated with risk of gastric cancer. The
divergent associations with Alu and LINE-1 raise the possibility
that the roles of DNA methylation in these two elements are
different in gastric cancer aetiology. However, replication is
needed before further inference may be drawn from these
observations.
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Table 4 Association of LINE-1 methylation levels in blood leukocytes and risk of gastric cancer by potential effect modifiers
a
Q4 Q3 Q2 Q1
Ncase/control OR (95%) Ncase/control OR (95%) Ncase/control OR (95%) Ncase/control OR (95%) P
b
LINE-1 54/97 1 29/78 0.67 (0.39–1.15) 52/94 0.99 (0.62–1.60) 39/78 0.90 (0.54–1.50)
Family history(yes) 4/5 1 2/12 0.13 (0.01–1.55) 4/5 0.55 (0.09–3.57) 5/4 1.74 (0.27–11.1) 0.26
Family history (no) 50/92 1 38/82 0.75 (0.43–1.30) 45/83 1.03 (0.63–1.68) 26/64 0.82 (0.48–1.41)
Menopause (yes) 44/78 1 36/77 0.70 (0.39–1.26) 41/73 1.03 (0.61–1.74) 25/55 0.90 (0.51–1.58) 0.98
Menopause (no) 10/19 1 4/17 0.46 (0.11–2.04) 8/15 0.83 (0.26–2.59) 6/13 0.96 (0.29–3.15)
Tea (yes) 16/29 1 6/22 0.35 (0.10–1.18) 13/27 1.08 (0.43–2.70) 7/25 0.52 (0.20–1.37) 0.34
Tea (no) 38/68 1 34/72 0.78 (0.42–1.45) 36/61 0.97 (0.56–1.70) 24/43 1.14 (0.62–2.10)
Isoflavone (high) 25/44 1 18/50 0.84 (0.40–1.77) 30/42 0.85 (0.44–1.66) 12/31 0.88 (0.44–1.78) 0.65
Isoflavone (low) 29/53 1 22/44 0.54 (0.24–1.18) 19/46 1.15 (0.58–2.27) 19/37 0.91 (0.43–1.91)
Folic acid (high) 24/52 1 16/43 0.61 (0.30–1.26) 29/43 0.75 (0.38–1.48) 13/33 0.74 (0.36–1.50) 0.36
Folic acid (low) 30/45 1 24/51 0.70 (0.31–1.62) 20/45 1.28 (0.65–2.52) 18/35 1.08 (0.52–2.26)
Vegetable (high) 28/53 1 22/40 0.41 (0.18–0.92) 31/46 0.91 (0.46–1.82) 17/39 0.71 (0.32–1.58) 0.74
Vegetable (low) 26/44 1 18/54 1.08 (0.52–2.26) 18/42 1.06 (0.55–2.04) 14/29 1.06 (0.54–2.08)
Fruit (high) 21/47 1 18/44 0.56 (0.27–1.16) 27/50 0.90 (0.46–1.76) 19/33 0.60 (0.28–1.26) 0.16
Fruit (low) 33/50 1 22/50 0.83 (0.37–1.89) 22/38 1.16 (0.58–2.33) 12/35 1.34 (0.65–2.76)
Abbreviations: OR¼odds ratio; LINE¼long interspersed nucleotide elements.
aAdjusted for age; subjects with latency o1 year were excluded.
bP-value for interaction tested
by coding the LINE-1 as ordinal variable (1,2,3,4).
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